ACCD Company Profile and Key Details
Accolade, Inc.
ACCD Stock Price Chart
Stock Price Today
Accolade, Inc. (ACCD) stock surged +0.73%, trading at $6.94 on NASDAQ, up from the previous close of $6.89. The stock opened at $6.88, fluctuating between $6.86 and $6.94 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Company Information
| Employees | 2400 |
| Beta | 2.02 |
| Sales or Revenue | $414.29M |
| 5Y Sales Change% | 1.297% |
| Fiscal Year Ends | February |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Frequently Asked Questions
Accolade, Inc. (NASDAQ: ACCD) stock price is $6.94 in the last trading session. During the trading session, ACCD stock reached the peak price of $6.94 while $6.86 was the lowest point it dropped to. The percentage change in ACCD stock occurred in the recent session was 0.73% while the dollar amount for the price change in ACCD stock was $0.05.
The NASDAQ listed ACCD is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Accolade, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Rajeev Singh
Chairman & Chief Executive Officer
Mr. Colin McHugh
Chief Accounting Officer
Mr. Robert Cavanaugh
Pres
Mr. Todd Friedman
Senior Vice President of Investor Relations
Ms. Carolina Lobo
Chief Marketing Officer
Ms. Kristen Keating Weeks
Senior Vice President of Strategy, Corporation Devel. & Partnerships
Mr. Michael W. Hilton
Chief Innovation Officer
Mr. Stephen H. Barnes CPA
Chief Financial Officer & Treasurer
Ms. Adriane Musuneggi
Vice President of Product Management & Experience
Mr. Drew Garner
Executive Vice President of Advocacy Devel.
Ms. Kristen Bruzek
Senior Vice President of Bus. Operations
Mr. Todd Clardy
Executive Vice President & GM of Gov. Solutions
Mr. Ryan McQuaid
Executive Vice President of Product & Member Marketing
Dr. Shantanu Nundy M.B.A., M.D.
Executive Vice President of Care Delivery, Chief Health Officer & Member of the Medical Advisory Board
Mr. Richard Eskew
Executive Vice President, Gen. Counsel, CCO & Sec.
ACCD's closing price is 125.33% higher than its 52-week low of $3.08 where as its distance from 52-week high of $13.93 is -50.18%.
Number of ACCD employees currently stands at 2,400.
Official Website of ACCD is: https://www.accolade.com
ACCD could be contacted at phone 206 926 8100 and can also be accessed through its website. ACCD operates from 660 West Germantown Pike, Plymouth Meeting, PA 19462, United States.
ACCD stock volume for the day was 1.64M shares. The average number of ACCD shares traded daily for last 3 months was 2M.
The market value of ACCD currently stands at $566.85M with its latest stock price at $6.94 and 81.68M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com